Jubilant isn’t the only one with new jobs, others are hiring right now! Check it out! (Isn’t it tempting?)
Jubilant Pharma to raise around $50 million from International Finance corporation and another $60 million by way of quasi-equity. With this financing, JLS plans to consolidate its pharmaceutical business under JPL. This financing package will help Jubilant Life Sciences Limited, India (JLS the Parent of Jubliant Pharma) to de-couple its pharmaceutical business from its life science ingredients (LSI) business and enhance shareholder value. The proposed IFC-led financing package will help provide a counter cyclical and long-term financial support to Jubilant Pharma Limited, Singapore (JPL) and through JPL, to its parent company, Jubilant Life Sciences Limited, India (JLS or the Parent).
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
